+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

NGS-based RNA-seq - Global Market Trajectory & Analytics

  • ID: 4805270
  • Report
  • September 2020
  • Region: Global
  • 218 pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Agilent Technologies
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ag
  • Gatc Biotech Ag
  • Illumina
  • Macrogen
  • MORE
Global NGS-based RNA-seq Market to Reach $5.3 Billion by 2027

Amid the COVID-19 crisis, the global market for NGS-based RNA-seq estimated at US$1.5 Billion in the year 2020, is projected to reach a revised size of US$5.3 Billion by 2027, growing at a CAGR of 19.9% over the analysis period 2020-2027. Sample Preparation, one of the segments analyzed in the report, is projected to record a 16% CAGR and reach US$998.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Sequencing Platforms & Consumables for RNA-Seq segment is readjusted to a revised 22.8% CAGR for the next 7-year period.

The U. S. Market is Estimated at $438 Million, While China is Forecast to Grow at 19.3% CAGR

The NGS-based RNA-seq market in the U. S. is estimated at US$438 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$918.6 Million by the year 2027 trailing a CAGR of 19.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.8% and 17.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 14.8% CAGR.

RNA Sequencing Services Segment to Record 20.2% CAGR

In the global RNA Sequencing Services segment, USA, Canada, Japan, China and Europe will drive the 20% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$284 Million in the year 2020 will reach a projected size of US$1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$654.6 Million by the year 2027. We bring years of research experience to this 9th edition of our report. The 218-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:
  • Agilent Technologies, Inc.
  • Eurofins Scientific
  • F. Hoffmann-La Roche AG
  • GATC Biotech AG
  • Illumina, Inc.
  • Macrogen, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Agilent Technologies
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ag
  • Gatc Biotech Ag
  • Illumina
  • Macrogen
  • MORE
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • RNA-Seq: An Introduction
  • A Prelude to NGS-based RNA-seq Market
  • North America: The Largest Market for NGS-based RNA-seq
  • Global Competitor Market Shares
  • NGS-based RNA-seq Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
  • NGS-based RNA-seq Market Drivers and Restraints
  • Recent Advances in RNA Sequence Analysis
  • Select Players of NGS-based RNA-seq Market
  • Rise in Research Grants to Improve Activities in NGS-based RNA-Sequencing Technique
  • Application of RNA-Seq in Precision Medicine
  • Next Generation Sequencing in Cancer Research
  • Next Generation Sequencing for Transcriptomic Profiling
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: NGS-based RNA-seq Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
  • TABLE 2: NGS-based RNA-seq Market Share Shift across Key Geographies Worldwide: 2020 VS 2027
  • TABLE 3: Sample Preparation (Products & Services) World Market by Region/Country in US$ Thousand: 2020 to 2027
  • TABLE 4: Sample Preparation (Products & Services) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027
  • TABLE 5: Sequencing Platforms & Consumables for RNA-Seq (Products & Services) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027
  • TABLE 6: Sequencing Platforms & Consumables for RNA-Seq (Products & Services) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027
  • TABLE 7: RNA Sequencing Services (Products & Services) Geographic Market Spread Worldwide in US$ Thousand: 2020 to 2027
  • TABLE 8: RNA Sequencing Services (Products & Services) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
  • TABLE 9: Data Analysis, Storage, and Management (Products & Services) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2020 to 2027
  • TABLE 10: Data Analysis, Storage, and Management (Products & Services) Market Share Breakdown by Region/Country: 2020 VS 2027
  • TABLE 11: Sequencing by Synthesis (SBS) (Technology) World Market by Region/Country in US$ Thousand: 2020 to 2027
  • TABLE 12: Sequencing by Synthesis (SBS) (Technology) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
  • TABLE 13: Ion Semiconductor Sequencing (Technology) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020 to 2027
  • TABLE 14: Ion Semiconductor Sequencing (Technology) Market Percentage Share Distribution by Region/Country: 2020 VS 2027
  • TABLE 15: Single-molecule Real-time (SMRT) Sequencing (Technology) Market Opportunity Analysis Worldwide in US$ Thousand by Region/Country: 2020 to 2027
  • TABLE 16: Single-molecule Real-time (SMRT) Sequencing (Technology) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
  • TABLE 17: Nanopore Sequencing (Technology) World Market by Region/Country in US$ Thousand: 2020 to 2027
  • TABLE 18: Nanopore Sequencing (Technology) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027
  • TABLE 19: De Novo Transcriptome Assembly (Application) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2020-2027
  • TABLE 20: De Novo Transcriptome Assembly (Application) Market Share Breakdown by Region/Country: 2020 VS 2027
  • TABLE 21: Expression Profiling Analysis (Application) Demand Potential Worldwide in US$ Thousand by Region/Country: 2020-2027
  • TABLE 22: Expression Profiling Analysis (Application) Share Breakdown Review by Region/Country: 2020 VS 2027
  • TABLE 23: Variant Calling and Transcriptome Epigenetics (Application) Worldwide Latent Demand Forecasts in US$ Thousand by Region/Country: 2020-2027
  • TABLE 24: Variant Calling and Transcriptome Epigenetics (Application) Distribution of Global Sales by Region/Country: 2020 VS 2027
  • TABLE 25: Small RNA Sequencing (Application) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2020 through 2027
  • TABLE 26: Small RNA Sequencing (Application) Global Market Share Distribution by Region/Country for 2020 and 2027
  • TABLE 27: Research Centers & Academic & Government Institutes (End-Use) Global Opportunity Assessment in US$ Thousand by Region/Country: 2020-2027
  • TABLE 28: Research Centers & Academic & Government Institutes (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2020 VS 2027
  • TABLE 29: Hospitals & Clinics (End-Use) Worldwide Sales in US$ Thousand by Region/Country: 2020-2027
  • TABLE 30: Hospitals & Clinics (End-Use) Market Share Shift across Key Geographies: 2020 VS 2027
  • TABLE 31: Pharmaceutical & Biotechnology Companies (End-Use) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2020-2027
  • TABLE 32: Pharmaceutical & Biotechnology Companies (End-Use) Market Share Breakdown by Region/Country: 2020 VS 2027
  • TABLE 33: Other End-Uses (End-Use) Demand Potential Worldwide in US$ Thousand by Region/Country: 2020-2027
  • TABLE 34: Other End-Uses (End-Use) Share Breakdown Review by Region/Country: 2020 VS 2027
III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
  • Market Facts & Figures
  • US NGS-based RNA-seq Market Share (in %) by Company: 2019 & 2025
  • Market Analytics
  • TABLE 35: United States NGS-based RNA-seq Market Estimates and Projections in US$ Thousand by Products & Services: 2020 to 2027
  • TABLE 36: United States NGS-based RNA-seq Market Share Breakdown by Products & Services: 2020 VS 2027
  • TABLE 37: NGS-based RNA-seq Market in US$ Thousand in the United States by Technology: 2020-2027
  • TABLE 38: United States NGS-based RNA-seq Market Share Breakdown by Technology: 2020 VS 2027
  • TABLE 39: United States NGS-based RNA-seq Latent Demand Forecasts in US$ Thousand by Application: 2020 to 2027
  • TABLE 40: NGS-based RNA-seq Market Share Breakdown in the United States by Application: 2020 VS 2027
  • TABLE 41: United States NGS-based RNA-seq Latent Demand Forecasts in US$ Thousand by End-Use: 2020 to 2027
  • TABLE 42: NGS-based RNA-seq Market Share Breakdown in the United States by End-Use: 2020 VS 2027
CANADA
  • TABLE 43: Canadian NGS-based RNA-seq Market Estimates and Forecasts in US$ Thousand by Products & Services: 2020 to 2027
  • TABLE 44: NGS-based RNA-seq Market in Canada: Percentage Share Breakdown of Sales by Products & Services for 2020 and 2027
  • TABLE 45: NGS-based RNA-seq Market Analysis in Canada in US$ Thousand by Technology: 2020-2027
  • TABLE 46: Canadian NGS-based RNA-seq Market Share Breakdown by Technology: 2020 VS 2027
  • TABLE 47: Canadian NGS-based RNA-seq Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027
  • TABLE 48: Canadian NGS-based RNA-seq Market Share Analysis by Application: 2020 VS 2027
  • TABLE 49: Canadian NGS-based RNA-seq Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027
  • TABLE 50: Canadian NGS-based RNA-seq Market Share Analysis by End-Use: 2020 VS 2027
JAPAN
  • TABLE 51: Japanese Market for NGS-based RNA-seq: Annual Sales Estimates and Projections in US$ Thousand by Products & Services for the Period 2020-2027
  • TABLE 52: Japanese NGS-based RNA-seq Market Share Analysis by Products & Services: 2020 VS 2027
  • TABLE 53: Japanese Medium & Long-Term Outlook for NGS-based RNA-seq Market in US$ Thousand by Technology: 2020-2027
  • TABLE 54: Japanese NGS-based RNA-seq Market Percentage Share Distribution by Technology: 2020 VS 2027
  • TABLE 55: Japanese Demand Estimates and Forecasts for NGS-based RNA-seq in US$ Thousand by Application: 2020 to 2027
  • TABLE 56: NGS-based RNA-seq Market Share Shift in Japan by Application: 2020 VS 2027
  • TABLE 57: Japanese Demand Estimates and Forecasts for NGS-based RNA-seq in US$ Thousand by End-Use: 2020 to 2027
  • TABLE 58: NGS-based RNA-seq Market Share Shift in Japan by End-Use: 2020 VS 2027
CHINA
  • TABLE 59: Chinese NGS-based RNA-seq Market Growth Prospects in US$ Thousand by Products & Services for the Period 2020-2027
  • TABLE 60: Chinese NGS-based RNA-seq Market by Products & Services: Percentage Breakdown of Sales for 2020 and 2027
  • TABLE 61: NGS-based RNA-seq Market Estimates and Forecasts in China in US$ Thousand by Technology: 2020-2027
  • TABLE 62: NGS-based RNA-seq Market in China: Percentage Share Analysis by Technology for 2020 and 2027
  • TABLE 63: Chinese Demand for NGS-based RNA-seq in US$ Thousand by Application: 2020 to 2027
  • TABLE 64: Chinese NGS-based RNA-seq Market Share Breakdown by Application: 2020 VS 2027
  • TABLE 65: Chinese Demand for NGS-based RNA-seq in US$ Thousand by End-Use: 2020 to 2027
  • TABLE 66: Chinese NGS-based RNA-seq Market Share Breakdown by End-Use: 2020 VS 2027
EUROPE
  • Market Facts & Figures
  • European NGS-based RNA-seq Market: Competitor Market Share Scenario (in %) for 2019 & 2025
  • Market Analytics
  • TABLE 67: European NGS-based RNA-seq Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025
  • TABLE 68: European NGS-based RNA-seq Market Share Shift by Region/Country: 2020 VS 2027
  • TABLE 69: European NGS-based RNA-seq Market Estimates and Forecasts in US$ Thousand by Products & Services: 2020-2027
  • TABLE 70: European NGS-based RNA-seq Market Share Breakdown by Products & Services: 2020 VS 2027
  • TABLE 71: European NGS-based RNA-seq Market Assessment in US$ Thousand by Technology: 2020-2027
  • TABLE 72: NGS-based RNA-seq Market in Europe: Percentage Breakdown of Sales by Technology for 2020 and 2027
  • TABLE 73: European NGS-based RNA-seq Addressable Market Opportunity in US$ Thousand by Application: 2020-2027
  • TABLE 74: European NGS-based RNA-seq Market Share Analysis by Application: 2020 VS 2027
  • TABLE 75: European NGS-based RNA-seq Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027
  • TABLE 76: European NGS-based RNA-seq Market Share Analysis by End-Use: 2020 VS 2027
FRANCE
  • TABLE 77: NGS-based RNA-seq Market in France by Products & Services: Estimates and Projections in US$ Thousand for the Period 2020-2027
  • TABLE 78: French NGS-based RNA-seq Market Share Analysis by Products & Services: 2020 VS 2027
  • TABLE 79: French NGS-based RNA-seq Market Estimates and Projections in US$ Thousand by Technology: 2020-2027
  • TABLE 80: French NGS-based RNA-seq Market Share Breakdown by Technology: 2020 VS 2027
  • TABLE 81: NGS-based RNA-seq Quantitative Demand Analysis in France in US$ Thousand by Application: 2020-2027
  • TABLE 82: French NGS-based RNA-seq Market Share Analysis: A 7-Year Perspective by Application for 2020 and 2027
  • TABLE 83: NGS-based RNA-seq Quantitative Demand Analysis in France in US$ Thousand by End-Use: 2020-2027
  • TABLE 84: French NGS-based RNA-seq Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027
GERMANY
  • TABLE 85: NGS-based RNA-seq Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Products & Services for the Period 2020-2027
  • TABLE 86: German NGS-based RNA-seq Market Share Breakdown by Products & Services: 2020 VS 2027
  • TABLE 87: German NGS-based RNA-seq Latent Demand Forecasts in US$ Thousand by Technology: 2020-2027
  • TABLE 88: German NGS-based RNA-seq Market Share Breakdown by Technology: 2020 VS 2027
  • TABLE 89: NGS-based RNA-seq Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2020-2027
  • TABLE 90: NGS-based RNA-seq Market Share Distribution in Germany by Application: 2020 VS 2027
  • TABLE 91: NGS-based RNA-seq Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2020-2027
  • TABLE 92: NGS-based RNA-seq Market Share Distribution in Germany by End-Use: 2020 VS 2027
ITALY
  • TABLE 93: Italian NGS-based RNA-seq Market Growth Prospects in US$ Thousand by Products & Services for the Period 2020-2027
  • TABLE 94: Italian NGS-based RNA-seq Market by Products & Services: Percentage Breakdown of Sales for 2020 and 2027
  • TABLE 95: NGS-based RNA-seq Market Estimates and Forecasts in Italy in US$ Thousand by Technology: 2020-2027
  • TABLE 96: NGS-based RNA-seq Market in Italy: Percentage Share Analysis by Technology for 2020 and 2027
  • TABLE 97: Italian Demand for NGS-based RNA-seq in US$ Thousand by Application: 2020 to 2027
  • TABLE 98: Italian NGS-based RNA-seq Market Share Breakdown by Application: 2020 VS 2027
  • TABLE 99: Italian Demand for NGS-based RNA-seq in US$ Thousand by End-Use: 2020 to 2027
  • TABLE 100: Italian NGS-based RNA-seq Market Share Breakdown by End-Use: 2020 VS 2027
UNITED KINGDOM
  • TABLE 101: United Kingdom Market for NGS-based RNA-seq: Annual Sales Estimates and Projections in US$ Thousand by Products & Services for the Period 2020-2027
  • TABLE 102: United Kingdom NGS-based RNA-seq Market Share Analysis by Products & Services: 2020 VS 2027
  • TABLE 103: United Kingdom Medium & Long-Term Outlook for NGS-based RNA-seq Market in US$ Thousand by Technology: 2020-2027
  • TABLE 104: United Kingdom NGS-based RNA-seq Market Percentage Share Distribution by Technology: 2020 VS 2027
  • TABLE 105: United Kingdom Demand Estimates and Forecasts for NGS-based RNA-seq in US$ Thousand by Application: 2020 to 2027
  • TABLE 106: NGS-based RNA-seq Market Share Shift in the United Kingdom by Application: 2020 VS 2027
  • TABLE 107: United Kingdom Demand Estimates and Forecasts for NGS-based RNA-seq in US$ Thousand by End-Use: 2020 to 2027
  • TABLE 108: NGS-based RNA-seq Market Share Shift in the United Kingdom by End-Use: 2020 VS 2027
REST OF EUROPE
  • TABLE 109: Rest of Europe NGS-based RNA-seq Market Estimates and Forecasts in US$ Thousand by Products & Services: 2020-2027
  • TABLE 110: Rest of Europe NGS-based RNA-seq Market Share Breakdown by Products & Services: 2020 VS 2027
  • TABLE 111: Rest of Europe NGS-based RNA-seq Market Assessment in US$ Thousand by Technology: 2020-2027
  • TABLE 112: NGS-based RNA-seq Market in Rest of Europe: Percentage Breakdown of Sales by Technology for 2020 and 2027
  • TABLE 113: Rest of Europe NGS-based RNA-seq Addressable Market Opportunity in US$ Thousand by Application: 2020-2027
  • TABLE 114: Rest of Europe NGS-based RNA-seq Market Share Analysis by Application: 2020 VS 2027
  • TABLE 115: Rest of Europe NGS-based RNA-seq Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027
  • TABLE 116: Rest of Europe NGS-based RNA-seq Market Share Analysis by End-Use: 2020 VS 2027
ASIA-PACIFIC
  • TABLE 117: NGS-based RNA-seq Market in Asia-Pacific by Products & Services: Estimates and Projections in US$ Thousand for the Period 2020-2027
  • TABLE 118: Asia-Pacific NGS-based RNA-seq Market Share Analysis by Products & Services: 2020 VS 2027
  • TABLE 119: Asia-Pacific NGS-based RNA-seq Market Estimates and Projections in US$ Thousand by Technology: 2020-2027
  • TABLE 120: Asia-Pacific NGS-based RNA-seq Historic Market Analysis in US$ Thousand by Technology: 2020 VS 2027
  • TABLE 121: NGS-based RNA-seq Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2020-2027
  • TABLE 122: Asia-Pacific NGS-based RNA-seq Market Share Analysis: A 7-Year Perspective by Application for 2020 and 2027
  • TABLE 123: NGS-based RNA-seq Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use: 2020-2027
  • TABLE 124: Asia-Pacific NGS-based RNA-seq Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027
REST OF WORLD
  • TABLE 125: Rest of World NGS-based RNA-seq Market Estimates and Forecasts in US$ Thousand by Products & Services: 2020 to 2027
  • TABLE 126: NGS-based RNA-seq Market in Rest of World: Percentage Share Breakdown of Sales by Products & Services for 2020 and 2027
  • TABLE 127: NGS-based RNA-seq Market Analysis in Rest of World in US$ Thousand by Technology: 2020-2027
  • TABLE 128: Rest of World NGS-based RNA-seq Market Share Breakdown by Technology: 2020 VS 2027
  • TABLE 129: Rest of World NGS-based RNA-seq Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027
  • TABLE 130: Rest of World NGS-based RNA-seq Market Share Analysis by Application: 2020 VS 2027
  • TABLE 131: Rest of World NGS-based RNA-seq Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027
  • TABLE 132: Rest of World NGS-based RNA-seq Market Share Analysis by End-Use: 2020 VS 2027
IV. COMPETITION
  • Total Companies Profiled: 46
Note: Product cover images may vary from those shown
3 of 3
  • Agilent Technologies
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ag
  • Gatc Biotech Ag
  • Illumina
  • Macrogen
  • Oxford Nanopore Technologies
  • Pacific Biosciences Of California
  • Perkinelmer
  • Qiagen Nv
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
Adroll
adroll